Search research articles
Contact Us
Filters
Showing results (51-60 of 164) with videos related to
Page
of 17
Sort By:
Medical Hypotheses
|
August 14, 2013
Perioperative ketorolac in high risk breast cancer patients. Rationale, feasibility and methodology of a prospective randomized placebo-controlled trial
Patrice Forget, Martine Berlière, Aline van Maanen, et al.
BJU International
|
June 21, 2014
Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer
Stéphane Oudard, Gero Kramer, Orazio Caffo, et al.
BMC Cancer
|
February 23, 2008
Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
Martine Berliere, Florence Dalenc, Nathalie Malingret, et al.
Frontiers in Oncology
|
April 4, 2019
Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck
Emmanuel Seront, Sandra Schmitz, Matthias Papier, et al.
Genome Medicine
|
April 10, 2009
A kernel-based integration of genome-wide data for clinical decision support
Anneleen Daemen, Olivier Gevaert, Fabian Ojeda, et al.
JCO Oncology Practice
|
May 13, 2026
Effect of a Single-Session Therapeutic Patient Education Intervention on Physical Activity in Patients Initiating Cancer Therapy: A Randomized Controlled Trial
Anne-Claire Latiers, Titouan Pautre, Lia Baudet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 19, 2007
Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?
Catherine Hubert, Christine Sempoux, Yves Horsmans, et al.
Molecular Cancer Therapeutics
|
January 12, 2020
Preclinical Activity of Ribociclib in Squamous Cell Carcinoma of the Head and Neck
Gabrielle van Caloen, Sandra Schmitz, Mariama El Baroudi, et al.
Plos One
|
July 11, 2013
Tamoxifen and ovarian function
Martine Berliere, Francois P Duhoux, Florence Dalenc, et al.
Cancer Chemotherapy and Pharmacology
|
September 10, 2015
A phase I study of volasertib combined with afatinib, in advanced solid tumors
Jean-Pascal Machiels, Marc Peeters, Catherine Herremans, et al.
Page
of 17
Search research articles
Search
Showing results (51-60 of 164) with videos related to
Sort By:
Page
of 17
Medical Hypotheses
|
August 14, 2013
Perioperative ketorolac in high risk breast cancer patients. Rationale, feasibility and methodology of a prospective randomized placebo-controlled trial
Patrice Forget, Martine Berlière, Aline van Maanen, et al.
BJU International
|
June 21, 2014
Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer
Stéphane Oudard, Gero Kramer, Orazio Caffo, et al.
BMC Cancer
|
February 23, 2008
Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel
Martine Berliere, Florence Dalenc, Nathalie Malingret, et al.
Frontiers in Oncology
|
April 4, 2019
Phase 1 Study Evaluating the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib and Cetuximab in Recurrent/Metastatic p16-Negative Squamous Cell Carcinoma of the Head and Neck
Emmanuel Seront, Sandra Schmitz, Matthias Papier, et al.
Genome Medicine
|
April 10, 2009
A kernel-based integration of genome-wide data for clinical decision support
Anneleen Daemen, Olivier Gevaert, Fabian Ojeda, et al.
JCO Oncology Practice
|
May 13, 2026
Effect of a Single-Session Therapeutic Patient Education Intervention on Physical Activity in Patients Initiating Cancer Therapy: A Randomized Controlled Trial
Anne-Claire Latiers, Titouan Pautre, Lia Baudet, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 19, 2007
Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?
Catherine Hubert, Christine Sempoux, Yves Horsmans, et al.
Molecular Cancer Therapeutics
|
January 12, 2020
Preclinical Activity of Ribociclib in Squamous Cell Carcinoma of the Head and Neck
Gabrielle van Caloen, Sandra Schmitz, Mariama El Baroudi, et al.
Plos One
|
July 11, 2013
Tamoxifen and ovarian function
Martine Berliere, Francois P Duhoux, Florence Dalenc, et al.
Cancer Chemotherapy and Pharmacology
|
September 10, 2015
A phase I study of volasertib combined with afatinib, in advanced solid tumors
Jean-Pascal Machiels, Marc Peeters, Catherine Herremans, et al.
Page
of 17